Evaluation of methodologies for indirect comparison of eplontersen and vutrisiran for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy

被引：0
|
作者：
Karam, Chafic [1 ]
Gillmore, Julian [2 ]
Chen, Gengshi [3 ]
Jenkins, Nia [4 ]
Hale, Mike [4 ]
Taylor, Gemma [4 ]
Chen, Jersey [3 ]
Viney, Nicholas [5 ]
Schneider, Eugene [5 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] UCL, Los Angeles, CA USA
[3] Astra Zeneca, Cambridge, MA USA
[4] HEOR Ltd, Cardiff, Wales
[5] Ionis Pharmaceut Inc, Carlsbad, CA USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000202150
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P12-4.005
引用
收藏
页数：4
相关论文
共 50 条
  • [31] HELIOS-A: 9-month results from the phase 3 study of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Adams, Davide
    Tournev, Ivailo
    Taylor, Mark
    Coelho, Teresa
    Plante-Bordeneuve, Violaine
    Berk, John
    Gonzalez-Duarte, Alejandra
    Gillmore, Julian
    Low, Soon-Chai
    Sekijima, Yoshiki
    Obici, Laura
    Blakesley, Rick
    Arum, Seth
    Shilling, Rebecca
    Vest, John
    Polydefkis, Michael
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [32] Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Labeyrie, Celine
    Merkel, Madeline
    Sethi, Sakshi
    Popadic, Lyuba
    Yang, Hongbo
    Sweetser, Marianne T.
    Lin, Hollis
    Adams, David
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (09)
  • [33] LONGTERM TREATMENT EFFECTS OF INOTERSEN ON QUALITY OF LIFE IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
    Brown, Duncan
    Karam, Chafic
    Yang, Min
    Done, Nicolae
    Zhu, JingJing
    Greatsinger, Ali
    Bozas, Ana
    Llonch, Montserrat Vera
    Signorovitch, James
    MUSCLE & NERVE, 2021, 64 : S57 - S57
  • [34] HELIOS-A: NINE-MONTH RESULTS FROM THE PHASE 3 STUDY OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
    Adams, David
    Tournev, Ivailo
    Taylor, Mark
    Coelho, Teresa
    Plante-Bordeneuve, Violaine
    Berk, John
    Gonzalez-Duarte, Alejandra
    Gillmore, Julian
    Low, Soon-Chai
    Sekijima, Yoshiki
    Obici, Laura
    Blakesley, Rick
    Arum, Seth
    Shilling, Rebecca
    Vest, John
    Polydefkis, Michael
    MUSCLE & NERVE, 2021, 64 : S54 - S55
  • [35] HELIOS-A: 9-month Results from the Phase 3 Study of Vutrisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
    Adams, David
    Tournev, Ivailo L.
    Taylor, Mark S.
    Coelho, Teresa
    Plante-Bordeneuve, Violaine
    Berk, John L.
    Gonzalez-Duarte, Alejandra
    Gillmore, Julian D.
    Low, Soon-Chai
    Sekijima, Yoshiki
    Obici, Laura
    Blakesley, Rick
    Arum, Seth
    Shilling, Rebecca
    Vest, John
    Polydefkis, Michael
    NEUROLOGY, 2021, 96 (15)
  • [36] Practical Guidance for the Use of Patisiran in the Management of Polyneuropathy in Hereditary Transthyretin-Mediated Amyloidosis
    Dixon, Stacy
    Kang, Xuan
    Quan, Dianna
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 973 - 981
  • [37] HELIOS-A: 9-month results from the phase 3 study of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Adams, David
    Tournev, Ivailo
    Taylor, Mark
    Coelho, Teresa
    Plante-Bordeneuve, Violaine
    Berk, John
    Gonzalez-Duarte, Alejandra
    Gillmore, Julian
    Low, Soon-Chai
    Sekijima, Yoshiki
    Obici, Laura
    Blakesley, Rick
    Arum, Seth
    Shilling, Rebecca
    Vest, John
    Polydefkis, Michael
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2021, 26 (03) : 309 - 309
  • [38] SWITCHING FROM INOTERSEN TO EPLONTERSEN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS POLYNEUROPATHY
    Conceicao, Isabel
    Weiler, Markus
    Kowacs, Pedro
    Dasgupta, Noel
    Khella, Sami
    Chao, Chi-Chao
    Attarian, Shahram
    Jung, Shiangtung
    Chen, Jersey
    Schneider, Eugene
    Viney, Nicholas
    Gertz, Morie
    Masri, Ahmad
    Cruz, Marcia Waddington
    Coelho, Teresa
    Berk, John
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S138 - S139
  • [39] Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis
    Kristen, Arnt, V
    Ajroud-Driss, Senda
    Conceicao, Isabel
    Gorevic, Peter
    Kyriakides, Theodoros
    Obici, Laura
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2019, 9 (01) : 5 - 24
  • [40] COST OF INOTERSEN AND PATISIRAN FOR THE TREATMENT OF ADULTS WITH POLYNEUROPATHY OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS IN CANADA, GERMANY, AND ITALY
    Brown, D.
    Vera-Llonch, M.
    Shaff, M.
    Rolli, A.
    Vega, M.
    Blum, M.
    Nestler-Parr, S.
    Jiresch, M.
    Weycker, D.
    VALUE IN HEALTH, 2020, 23 : S606 - S607
12345